258 related articles for article (PubMed ID: 17655599)
1. Evaluating the impact of public health notification of suspected transfusion-transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigations by Canadian Blood Services in British Columbia, Canada, August 2002 through February 2005.
Whitlock M; Lord S; Buxton JA; Doyle P; Bigham M
Transfusion; 2007 Aug; 47(8):1534-9. PubMed ID: 17655599
[TBL] [Abstract][Full Text] [Related]
2. Recent Canadian experience with targeted hepatitis C virus lookback.
Goldman M; Patterson L; Long A
Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C lookback in Canada.
Goldman M; Long A
Vox Sang; 2000; 78 Suppl 2():249-52. PubMed ID: 10938962
[TBL] [Abstract][Full Text] [Related]
4. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
Williams JL; Cagle HH; Christensen CJ; Fox-Leyva LK; McMahon BJ
Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
[TBL] [Abstract][Full Text] [Related]
5. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
[TBL] [Abstract][Full Text] [Related]
6. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
[TBL] [Abstract][Full Text] [Related]
7. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of transfusion-associated hepatitis C in a children's hospital.
Luban NL; Colvin CA; Mohan P; Alter HJ
Transfusion; 2007 Apr; 47(4):615-20. PubMed ID: 17381619
[TBL] [Abstract][Full Text] [Related]
9. Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis.
Takano S; Nakamura K; Kawai S; Yokosuka O; Satomura Y; Omata M
Hepatology; 1996 Apr; 23(4):708-12. PubMed ID: 8666321
[TBL] [Abstract][Full Text] [Related]
10. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
Angelotta C; McKoy JM; Fisher MJ; Buffie CG; Barfi K; Ramsey G; Frohlich L; Bennett CL
Vox Sang; 2007 Aug; 93(2):159-65. PubMed ID: 17683360
[TBL] [Abstract][Full Text] [Related]
11. Face-to-face interviewing in predonation screening: lack of effect on detected human immunodeficiency virus and hepatitis C virus infections.
O'Brien SF; Fan W; Ram SS; Goldman M; Nair RC; Chiavetta JA; Vamvakas EC
Transfusion; 2006 Aug; 46(8):1380-7. PubMed ID: 16934075
[TBL] [Abstract][Full Text] [Related]
12. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
13. Blood recipient notification for hepatitis C in Prince Edward Island.
Van Til LD; Sweet LE
CMAJ; 2000 Jan; 162(2):199-202. PubMed ID: 10674052
[TBL] [Abstract][Full Text] [Related]
14. Risk of transfusion-transmitted hepatitis C virus in a tertiary hospital in Nigeria.
Imarengiaye CO; Enosolease ME; Iribhogbe PE; Ehigiegba AE
Public Health; 2006 Mar; 120(3):274-8. PubMed ID: 16364383
[TBL] [Abstract][Full Text] [Related]
15. Prevention of posttransfusion hepatitis by screening with second-generation anti-HCV antibody and clinical features of HCV infection.
Nishikado T; Honda H; Kamamura M; Hibino S; Ito S
Tokushima J Exp Med; 1996 Jun; 43(1-2):25-37. PubMed ID: 8885686
[TBL] [Abstract][Full Text] [Related]
16. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
[TBL] [Abstract][Full Text] [Related]
17. Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital.
Diro E; Alemu S; G/Yohannes A
Ethiop Med J; 2008 Jan; 46(1):7-13. PubMed ID: 18711984
[TBL] [Abstract][Full Text] [Related]
18. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
19. A Canadian hospital-based HIV/hepatitis C look-back notification program.
Heddle N; Kelton JG; Smaill F; Foss K; Everson J; Janzen C; Walker C; Jones M; Hammons D
CMAJ; 1997 Jul; 157(2):149-54. PubMed ID: 9238143
[TBL] [Abstract][Full Text] [Related]
20. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992.
Cagle HH; Jacob J; Homan CE; Williams JL; Christensen CJ; McMahon BJ
Arch Pediatr Adolesc Med; 2007 Feb; 161(2):125-30. PubMed ID: 17283296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
